WHC est encore en dévelopement. Lisez ceci pour comprendre notre approche.
depiction of QZVCTJOXCFMACW-UHFFFAOYSA-N.svg
isomerdesign

Phenoxybenzamine

Vérifier sur isomerdesign

pubchem

Phenoxybenzamine

Vérifier sur pubchem

drugmap

Phenoxybenzamine

Vérifier sur drugmap

Data

InChI: InChI=1S/C18H22ClNO/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17/h2-11,16H,12-15H2,1H3

Synonymes: KBio2_005754,GTPL7268, N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine,Bensylyt,CHEMBL753,Phenoxybenzamine (INN),NCGC00015121-03,Phenoxybenzaminum,HMS1990P19,BPBio1_001000,HMS1362P19, POB HCl,0TTZ664R7Z, Dibenzylin, 688A,(+/-)-PHENOXYBENZAMINE,Phenoxybenzamine,Fenoxibenzamina,NCGC00015121-07,NCGC00089748-03,688A,NINDS_000800, Bensylyte,PHENOXYBENZAMINE [HSDB], Dibenziran,SCHEMBL5722, N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine,4-12-00-02204 (Beilstein Handbook Reference), Dibenzyline (TN), Phenoxybenzamine (INN),Spectrum_000378,DTXSID0023458,C07435,HMS3403P19,N-Phenoxyisopropyl-N-benzyl-beta-chloroethylamine, Dibenzylene,HSDB 4005,KBioGR_000618,L001197,Fenossibenzamina, Fenossibenzamina,HY-B0431,Spectrum2_001815, Phenoxybenzamine Hcl,Tox21_110087,Benzyl(2-chloroethyl)-(1-methyl-2-phenoxyethyl)amine, Fenoxibenzamina,CHEBI:8077,Fenossibenzamina [DCIT],DivK1c_000800,SPBio_003067,AB00053702_13,Q419824,KBio3_001095,Bensylyte,KBio2_003186,NCGC00015121-05, N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine,AC-13214,DSSTox_CID_3458,KBio3_001096,FT-0778642,PHENOXYBENZAMINE [MI],Prestwick1_000944,NCGC00015121-16,KBio2_000858,N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine,DB00925,PHENOXYBENZAMINE [VANDF],Benzenemethanamine, N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-,BSPBio_002356,BRN 2129697,Prestwick2_000944,NCGC00015121-14,AB00053702_14,Bio2_000479, Dibenylin,Fenoxibenzamina [INN-Spanish],Benzylamine, N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-,59-96-1 (free),102737-84-8,NCGC00015121-04,N-Phenoxyisopropyl-N-benzyl-.beta.-chloroethylamine,NCGC00015121-06, Bensylyt NEN,N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine,KBio2_000618,DSSTox_GSID_23458, Fenoxibenzamina [INN-Spanish],AB00053702,59-96-1,Bensylit,BSPBio_000908,KBioSS_000858,BDBM50017679,Phenoxybenzaminum [INN-Latin],Prestwick0_000944, Dibenylene,CCRIS 505,CCG-204330, Benzylyt,NSC 37448,CAS-59-96-1, N-(2-chloroethyl)-N-(phenylmethyl)-1-(phenyloxy)propan-2-amine,SB82886,SBI-0050223.P003,Benzyl-(2-chloro-ethyl)-(1-methyl-2-phenoxy-ethyl)-amine,D08358,phenoxybenzamine,EINECS 200-446-8,Phenoxybenzamine [INN:BAN], N-Phenoxyisopropyl-N-benzyl-beta-chloroethylamine, Dibenzyran,N-Benzyl-N-(2-chloroethyl)-1-phenoxy-2-propanamine #, Phenoxybenzaminum,N-(2-chloroethyl)-N-(phenylmethyl)-1-(phenyloxy)propan-2-amine,KBio2_003426,IDI1_000800,HMS1792P19,Benzylyt,IDI1_002234,Dibenyline,NCGC00015121-08,Spectrum4_000769,NCGC00089748-07,SDCCGSBI-0050223.P004,benzyl(2-chloroethyl)(1-phenoxypropan-2-yl)amine,Lopac0_000235,BSPBio_001278, Dibenyline,N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine,HMS2089J09, A 688,NCGC00015121-09,KBioGR_001158,Dibenzyline,Prestwick3_000944, 2-(N-Benzyl-2-chloroethylamino)-1-phenoxypropane,NCGC00015121-13,PHENOXYBENZAMINE [WHO-DD],DSSTox_RID_77034,NCGC00015121-17,NCGC00015121-11,Dibenylin,NCGC00089748-04,SPBio_001829,A 688,KBio1_000800,NCGC00015121-12,AB00053702-12,Spectrum5_001370,2-(N-Benzyl-2-chloroethylamino)-1-phenoxypropane,KBioSS_000618,AKOS015961144, Phenoxybenzaminum [INN-Latin],Bensylytutn,Bio2_000959,CS-0255342, Fenossibenzamina [DCIT],Q-201556,KBio2_005994,PHENOXYBENZAMINE [INN],UNII-0TTZ664R7Z,MRF-0000619,Dibenylene,NCGC00089748-05,EN300-57590, Benzyl(2-chloroethyl)-(1-methyl-2-phenoxyethyl)amine,N-benzyl-N-(2-chloroethyl)-1-phenoxy-propan-2-amine,Tox21_110087_1

Estimated data

Solubility: -3.798 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 57.1% (prediction based on www.mdpi.com)

Similitudes

Voici une série de comparaisons visant à comprendre les propriétés de ce composé. Ce site est encore très expérimental et fait l'objet d'un développement actif. Veuillez vous référer à notre série d'articles d'articles pour bien comprendre notre approche et ses limites. Ces informations sont données à titre indicatif et ne doivent pas être interprétées comme des conseils médicaux.